Related Experiment Video
Updated: Jan 4, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM,
Ze Yu1, Hao Wang1, Yilin Fang1
1Key Laboratory of Saline-alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, Harbin, China.
Abstract:
Heat shock proteins (HSPs) were known as the molecular chaperones, which play a pivotal role in the protein quality control system, ensuring correct folding of proteins, and facilitating the correct refolding of damaged proteins via the transient interaction with their substrate proteins. They also practice in the regulation of cell cycles and are involved in apoptosis. We found that HspB2 was almost completely silent in pancreatic cancer and few studies investigated the role of HspB2 in cancer cells, particularly in pancreatic cancer. Here, we reported that HspB2 effectively inhibited cell proliferation in Panc-1 cells. Specifically, we demonstrated that HspB2 could combine mut-p53 and change the DNA binding site of mutant p53, subsequently upregulated the expression of RPRM, BAI-1, and TSAP6 which were the downstream genes of wt-p53, participate in mediating downstream responses to p53, including inhibiting cell proliferation and angiogenesis. The main aim of this study is to investigate the relationship between HspB2 and p53, and provide a novel treatment strategy for pancreatic cancer.
Insights
Heat shock protein B2 (HspB2) inhibits pancreatic cancer cell proliferation by interacting with mutant p53. This interaction upregulates tumor suppressor genes, offering a potential new treatment strategy for pancreatic cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Heat shock proteins (HSPs) are molecular chaperones crucial for protein quality control, cell cycle regulation, and apoptosis.
- HspB2 is often inactive in pancreatic cancer, with limited research on its role in cancer cells.
- Pancreatic cancer remains a significant health challenge with a need for novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of HspB2 in pancreatic cancer.
- To elucidate the relationship between HspB2 and p53 in pancreatic cancer cells.
- To explore HspB2 as a potential therapeutic target for pancreatic cancer.
Main Methods:
- Investigated HspB2 expression in pancreatic cancer cells (Panc-1).
- Examined the interaction between HspB2 and mutant p53 (mut-p53).
- Analyzed the downstream effects on p53 target genes (RPRM, BAI-1, TSAP6) and cellular processes like proliferation and angiogenesis.
Main Results:
- HspB2 significantly inhibited cell proliferation in Panc-1 cells.
- HspB2 was found to bind to mut-p53, altering its DNA-binding capabilities.
- Upregulation of wt-p53 downstream genes (RPRM, BAI-1, TSAP6) was observed, contributing to anti-proliferative and anti-angiogenic effects.
Conclusions:
- HspB2 plays a critical role in suppressing pancreatic cancer cell proliferation.
- The interaction between HspB2 and mut-p53 is a key mechanism driving these anti-cancer effects.
- Targeting the HspB2-p53 pathway presents a promising novel treatment strategy for pancreatic cancer.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway

